Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R. McCurdy(Johns Hopkins Hospital), Leo Luznik(Sidney Kimmel Comprehensive Cancer Center), Gary L. Rosner(The University of Texas MD Anderson Cancer Center), Heather J. Symons(Johns Hopkins University), B. Douglas Smith(Johns Hopkins University), Maria Bettinotti(Johns Hopkins University), William Matsui(Johns Hopkins University), Ivan Borrello(Johns Hopkins University), Amy E. DeZern(Johns Hopkins University), Richard J. Jones(Sidney Kimmel Cancer Center), Jennifer A. Kanakry(National Institutes of Health), Keith W. Pratz(Cancer Institute (WIA)), Ivana Gojo(Johns Hopkins University), Yvette L. Kasamon(Johns Hopkins University), Ephraim J. Fuchs(Johns Hopkins Hospital), Richard F. Ambinder(Johns Hopkins University), Christopher G. Kanakry(National Institutes of Health), Robert A. Brodsky(Johns Hopkins University), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Mark J. Levis(Johns Hopkins University), Margaret M. Showel(Johns Hopkins University), Hua-Ling Tsai(Johns Hopkins University), Douglas E. Gladstone(Northwell Health), Lode J. Swinnen(Johns Hopkins University), Javier Bolaños‐Meade(Johns Hopkins University)
Cited by 187
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655